FDG-PET response to nivolumab is predictive of tumor progression and survival in non-small cell lung cancer patients
Year: 2020
Type: article
Study design: Observational Study
Source: Journal of Nuclear Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3203485713
